Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Angela Sloan is active.

Publication


Featured researches published by Angela Sloan.


Emerging Infectious Diseases | 2017

Evaluation of 5 Commercially Available Zika Virus Immunoassays

David Safronetz; Angela Sloan; Derek R. Stein; Emelissa Mendoza; Nicole Barairo; Charlene Ranadheera; Leanne Scharikow; Kimberly Holloway; Alyssia Robinson; Maya Traykova-Andonova; Kai Makowski; Kristina Dimitrova; Elizabeth Giles; Joanne Hiebert; Rhonda Mogk; Sharla Beddome; Michael A. Drebot

Because of the global spread of Zika virus, accurate and high-throughput diagnostic immunoassays are needed. We compared the sensitivity and specificity of 5 commercially available Zika virus serologic assays to the recommended protocol of Zika virus IgM-capture ELISA and plaque-reduction neutralization tests. Most commercial immunoassays showed low sensitivity, which can be increased.


PLOS ONE | 2013

MS-H: a novel proteomic approach to isolate and type the E. coli H antigen using membrane filtration and liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Keding Cheng; Mike Drebot; Joanne McCrea; Lorea Peterson; David M. Lee; Stuart McCorrister; Richard Nickel; Alyssia Gerbasi; Angela Sloan; Debra Janella; Gary Van Domselaar; Daniel R. Beniac; Timothy F. Booth; Linda Chui; Helen Tabor; Garrett Westmacott; Matthew W. Gilmour; Gehua Wang

Serotyping is the long-standing gold standard method to determine E. coli H antigens; however, this method requires a panel of H-antigen specific antibodies and often culture-based induction of the H-antigen flagellar motility. In this study, a rapid and accurate method to isolate and identify the Escherichia coli (E. coli) H flagellar antigen was developed using membrane filtration and liquid chromatography-tandem mass spectrometry (LC-MS/MS). Flagella were isolated from pure culture, digested with trypsin, and then subjected to LC-MS/MS using one of two systems (Agilent-nano-LC-QSTAR XL or Proxeon-nano-LC-LTQ-Orbitrap XL). The resulting peptide sequence data were searched against a custom E. coli flagella/H antigen database. This approach was evaluated using flagella isolated from reference E. coli strains representing all 53 known H antigen types and 41 clinical E. coli strains. The resulting LC-MS/MS classifications of H antigen types (MS-H) were concordant with the known H serogroup for all 53 reference types, and of 41 clinical isolates tested, 38 (92.7%) were concordant with the known H serogroup. MS-H clearly also identified two clinical isolates (4.9%) that were untypeable by serotyping. Notably, successful detection and classification of flagellar antigens with MS-H did not generally require induction of motility, establishing this proteomic approach as more rapid and cost-effective than traditional methods, while providing equitable specificity for typing E. coli H antigens.


Journal of Clinical Microbiology | 2014

Comparative study of traditional flagellum serotyping and liquid chromatography-tandem mass spectrometry-based flagellum typing with clinical Escherichia coli isolates.

Keding Cheng; Angela Sloan; Lorea Peterson; Stuart McCorrister; Alyssia Robinson; Matthew Walker; T. Drew; J. McCrea; Linda Chui; J. Wylie; Sadjia Bekal; Aleisha Reimer; Garrett Westmacott; Mike Drebot; Celine Nadon; J. D. Knox; Gehua Wang

Keding Cheng, Angela Sloan, Lorea Peterson, Stuart McCorrister, Alyssia Robinson, Matthew Walker, Tracy Drew, Joanne McCrea, Linda Chui, John Wylie, Sadjia Bekal, Aleisha Reimer, Garrett Westmacott, Mike Drebot, Celine Nadon, J. David Knox, Gehua Wang National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada; Department of Human Anatomy and Cell Sciences, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Alberta Provincial Laboratory for Public Health, Calgary, Alberta, Canada; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada; Cadham Provincial Laboratory, Manitoba Health, Winnipeg, Manitoba, Canada; Laboratoire de Santé Publique du Quebéc, Saine-Anne-de-Bellevue, Quebéc, Canada; Department of Medical Microbiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada


BMC Research Notes | 2014

Fit-for-purpose curated database application in mass spectrometry-based targeted protein identification and validation

Keding Cheng; Angela Sloan; Stuart McCorrister; Shawn Babiuk; Timothy R. Bowden; Gehua Wang; J. David Knox

BackgroundMass spectrometry (MS) is a very sensitive and specific method for protein identification, biomarker discovery, and biomarker validation. Protein identification is commonly carried out by comparing MS data with public databases. However, with the development of high throughput and accurate genomic sequencing technology, public databases are being overwhelmed with new entries from different species every day. The application of these databases can also be problematic due to factors such as size, specificity, and unharmonized annotation of the molecules of interest. Current databases representing liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based searches focus on enzyme digestion patterns and sequence information and consequently, important functional information can be missed within the search output. Protein variants displaying similar sequence homology can interfere with database identification when only certain homologues are examined. In addition, recombinant DNA technology can result in products that may not be accurately annotated in public databases. Curated databases, which focus on the molecule of interest with clearer functional annotation and sequence information, are necessary for accurate protein identification and validation. Here, four cases of curated database application have been explored and summarized.FindingsThe four presented curated databases were constructed with clear goals regarding application and have proven very useful for targeted protein identification and biomarker application in different fields. They include a sheeppox virus database created for accurate identification of proteins with strong antigenicity, a custom database containing clearly annotated protein variants such as tau transcript variant 2 for accurate biomarker identification, a sheep-hamster chimeric prion protein (PrP) database constructed for assay development of prion diseases, and a custom Escherichia coli (E. coli) flagella (H antigen) database produced for MS-H, a new H-typing technique. Clearly annotating the proteins of interest was essential for highly accurate, specific, and sensitive sequence identification, and searching against public databases resulted in inaccurate identification of the sequence of interest, while combining the curated database with a public database reduced both the confidence and sequence coverage of the protein search.ConclusionCurated protein sequence databases incorporating clear annotations are very useful for accurate protein identification and fit-for-purpose application through MS-based biomarker validation.


Clinical Chemistry | 2016

Mass Spectrometry–Based Escherichia coli H Antigen/Flagella Typing: Validation and Comparison with Traditional Serotyping

Keding Cheng; She Ym; Chui H; Larissa Domish; Angela Sloan; Drexler Hernandez; Stuart McCorrister; Ma J; Xu B; Aleisha Reimer; Knox Jd; Gehua Wang

BACKGROUND Escherichia coli H antigen typing with antisera, a useful method for flagella clinical identification and classification, is a time-consuming process because of the need to induce flagella growth and the occurrence of undetermined strains. We developed an alternative rapid and analytically sensitive mass spectrometry (MS) method, termed MS-based H antigen typing (MS-H), and applied it at the protein sequence level for H antigen typing. We also performed a comparison with traditional serotyping on reference strains and clinical isolates. METHODS On the basis of international guidelines, the analytical selectivity and sensitivity, imprecision, correlation, repeatability, and reproducibility of the MS-H platform was evaluated using reference strains. Comparison of MS-H typing and serotyping was performed using 302 clinical isolates from 5 Canadian provinces, and discrepant results between the 2 platforms were resolved through whole genome sequencing. RESULTS Repeated tests on reference strain EDL933 demonstrated a lower limit of the measuring interval at the subsingle colony (16.97 μg or 1.465 × 10(7) cells) level and close correlation (r(2) > 0.99) between cell culture biomass and sequence coverage. The CV was <10.0% among multiple repeats with 4 reference strains. Intra- and interlaboratory tests demonstrated that the MS-H method was robust and reproducible under various sample preparation and instrumentation conditions. Using discrepancy analysis via whole genome sequencing, performed on isolates with discrepant results, MS-H accurately identified 12.3% more isolates than conventional serotyping. CONCLUSIONS MS-H typing of E. coli is useful for fast and accurate flagella typing and could be very useful during E. coli outbreaks.


PLOS ONE | 2014

Exploring Physical and Chemical Factors Influencing the Properties of Recombinant Prion Protein and the Real-Time Quaking-Induced Conversion (RT-QuIC) Assay

Keding Cheng; Angela Sloan; Kristen M. Avery; Michael B. Coulthart; Michael Carpenter; J. David Knox

Real-time quaking-induced conversion (RT-QuIC), a highly specific and sensitive assay able to detect low levels of the disease-inducing isoform of the prion protein (PrPd) in brain tissue biopsies and cerebral spinal fluid, has great potential to become a method for diagnosing prion disease ante mortem. In order to standardize the assay method for routine analysis, an understanding of how physical and chemical factors affect the stability of the recombinant prion protein (rPrP) substrate and the RT-QuIC assay’s sensitivity, specificity, and reproducibility is required. In this study, using sporadic Creutzfeldt-Jakob Disease brain homogenate to seed the reactions and an in vitro-expressed recombinant prion protein, hamster rPrP, as the substrate, the following factors affecting the RT-QuIC assay were examined: salt and substrate concentrations, substrate storage, and pH. Results demonstrated that both the generation of the quality and quantities of rPrP substrate critical to the reaction, as well as the RT-QuIC reaction itself required strict adherence to specific physical and chemical conditions. Once optimized, the RT-QuIC assay was confirmed to be a very specific and sensitive assay method for sCJD detection. Findings in this study indicate that further optimization and standardization of RT-QuIC assay is required before it can be adopted as a routine diagnostic test.


Proteomics Clinical Applications | 2014

Quality evaluation of LC-MS/MS-based E. coli H antigen typing (MS-H) through label-free quantitative data analysis in a clinical sample setup

Keding Cheng; Angela Sloan; Stuart McCorrister; Lorea Peterson; Huixia Chui; Mike Drebot; Celine Nadon; J. David Knox; Gehua Wang

The need for rapid and accurate H typing is evident during Escherichia coli outbreak situations. This study explores the transition of MS‐H, a method originally developed for rapid H antigen typing of E. coli using LC‐MS/MS of flagella digest of reference strains and some clinical strains, to E. coli isolates in clinical scenario through quantitative analysis and method validation.


Antiviral Research | 2017

Human polyclonal antibodies produced in transchromosomal cattle prevent lethal Zika virus infection and testicular atrophy in mice

Derek R. Stein; Joseph W. Golden; Bryan D. Griffin; Bryce M. Warner; Charlene Ranadheera; Leanne Scharikow; Angela Sloan; Kathy L. Frost; Darwyn Kobasa; Stephanie A. Booth; Matthew Josleyn; John Ballantyne; Eddie Sullivan; Jin-an Jiao; Hua Wu; Zhongde Wang; Jay W. Hooper; David Safronetz

ABSTRACT Zika virus (ZIKV) is rapidly spreading throughout the Americas and is associated with significant fetal complications, most notably microcephaly. Treatment with polyclonal antibodies for pregnant women at risk of ZIKV‐related complications could be a safe alternative to vaccination. We found that large quantities of human polyclonal antibodies could be rapidly produced in transchromosomal bovines (TcB) and successfully used to protect mice from lethal infection. Additionally, antibody treatment eliminated ZIKV induced tissue damage in immunologically privileged sites such as the brain and testes and protected against testicular atrophy. These data indicate that rapid development and deployment of human polyclonal antibodies could be a viable countermeasure against ZIKV. Graphical abstract Figure. No Caption available. HighlightsTranschromosomal Bovine (TcB) were developed to produce human polyclonal antibody.Vaccinated TcB produce high‐titer neutralizing antibody to Zika virus.Human ZIKV‐TcB antibodies prevent lethal disease in two mouse models.ZIKV‐TcB antibodies prevent tissue damage and testicular atrophy in mice.Delayed treatment results in significant protection from lethal ZIKV infection.


Journal of Clinical Microbiology | 2016

Endpoint Quaking-Induced Conversion: a Sensitive, Specific, and High-Throughput Method for Antemortem Diagnosis of Creutzfeldt-Jacob Disease.

Keding Cheng; Robert Vendramelli; Angela Sloan; Brooks Waitt; Lisa Podhorodecki; Debra Godal; J. David Knox

ABSTRACT The Prion Laboratory Section of the Public Health Agency of Canada supports heath care professionals dealing with patients suspected to have Creutzfeldt-Jakob disease (CJD) by testing cerebrospinal fluid (CSF) for protein markers of CJD. To better serve Canadian diagnostic requirements, a quaking-induced conversion (QuIC)-based assay has been added to the test panel. The QuIC tests exploit the ability of disease-associated prion protein, found in the CSF of a majority of CJD patients, to convert a recombinant prion protein (rPrP) into detectable amounts of a misfolded, aggregated form of rPrP. The rPrP aggregates interact with a specific dye, causing a measurable change in the dyes fluorescence emission spectrum. Optimal test and analysis parameters were empirically determined. Taking both practical and performance considerations into account, an endpoint QuIC (EP-QuIC) configuration was chosen. EP-QuIC uses a thermo-mixer to perform the shaking necessary to produce the quaking-induced conversions. Fluorescence readings are obtained from a microwell fluorescence reader only at the beginning and the end of EP-QuIC reactions. Samples for which the relative fluorescence unit ratio between the initial and final readings represent a ≥4 increase in signal intensity in at least two of the three replicates are classified as positive. A retrospective analysis of 91 CSF samples that included 45 confirmed cases of CJD and 46 non-CJD cases was used to estimate the performance characteristics of the EP-QuIC assay. The diagnostic sensitivity and specificity of the EP-QuIC test of this set of samples were 98 and 91%, respectively.


Journal of Clinical Microbiology | 2016

Phenotypic H-Antigen Typing by Mass Spectrometry Combined with Genetic Typing of H Antigens, O Antigens, and Toxins by Whole-Genome Sequencing Enhances Identification of Escherichia coli Isolates

Keding Cheng; Huixia Chui; Larissa Domish; Angela Sloan; Drexler Hernandez; Stuart McCorrister; Alyssia Robinson; Matthew Walker; Lorea Peterson; Miles Majcher; Sam Ratnam; David J. M. Haldane; Sadjia Bekal; John L. Wylie; Linda Chui; Shaun Tyler; Bianli Xu; Aleisha Reimer; Celine Nadon; J. David Knox; Gehua Wang

ABSTRACT Mass spectrometry-based phenotypic H-antigen typing (MS-H) combined with whole-genome-sequencing-based genetic identification of H antigens, O antigens, and toxins (WGS-HOT) was used to type 60 clinical Escherichia coli isolates, 43 of which were previously identified as nonmotile, H type undetermined, or O rough by serotyping or having shown discordant MS-H and serotyping results. Whole-genome sequencing confirmed that MS-H was able to provide more accurate data regarding H antigen expression than serotyping. Further, enhanced and more confident O antigen identification resulted from gene cluster based typing in combination with conventional typing based on the gene pair comprising wzx and wzy and that comprising wzm and wzt. The O antigen was identified in 94.6% of the isolates when the two genetic O typing approaches (gene pair and gene cluster) were used in conjunction, in comparison to 78.6% when the gene pair database was used alone. In addition, 98.2% of the isolates showed the existence of genes for various toxins and/or virulence factors, among which verotoxins (Shiga toxin 1 and/or Shiga toxin 2) were 100% concordant with conventional PCR based testing results. With more applications of mass spectrometry and whole-genome sequencing in clinical microbiology laboratories, this combined phenotypic and genetic typing platform (MS-H plus WGS-HOT) should be ideal for pathogenic E. coli typing.

Collaboration


Dive into the Angela Sloan's collaboration.

Top Co-Authors

Avatar

Keding Cheng

Public Health Agency of Canada

View shared research outputs
Top Co-Authors

Avatar

Gehua Wang

Public Health Agency of Canada

View shared research outputs
Top Co-Authors

Avatar

Stuart McCorrister

Public Health Agency of Canada

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mike Drebot

Public Health Agency of Canada

View shared research outputs
Top Co-Authors

Avatar

Celine Nadon

Public Health Agency of Canada

View shared research outputs
Top Co-Authors

Avatar

Garrett Westmacott

Public Health Agency of Canada

View shared research outputs
Top Co-Authors

Avatar

Lorea Peterson

Public Health Agency of Canada

View shared research outputs
Top Co-Authors

Avatar

Aleisha Reimer

Public Health Agency of Canada

View shared research outputs
Top Co-Authors

Avatar

Alyssia Robinson

Public Health Agency of Canada

View shared research outputs
Researchain Logo
Decentralizing Knowledge